Offer - Urjas Oil for just ₹ 1
Emcloz 0.25 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Emcloz 0.25 Tablet is used -
Severe
Moderate
Mild
Is the use of Emcloz 0.25 Tablet safe for pregnant women?
Emcloz may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Emcloz again without your doctor's advice.
Is the use of Emcloz 0.25 Tablet safe during breastfeeding?
Emcloz can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Emcloz 0.25 Tablet on the Kidneys?
Very few cases of side effects of Emcloz on kidney have been reported.
What is the effect of Emcloz 0.25 Tablet on the Liver?
Emcloz has very mild side effects on the liver.
What is the effect of Emcloz 0.25 Tablet on the Heart?
Emcloz is completely safe for the heart.
Emcloz 0.25 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Emcloz 0.25 Tablet unless your doctor advises you to do so -
Is this Emcloz 0.25 Tablet habit forming or addictive?
Yes, Emcloz 0.25 Tablet cause dependence in some cases. Talk to your doctor before taking it.
Is it safe to drive or operate heavy machinery when consuming?
After taking Emcloz 0.25 Tablet, you should not drive or work on any heavy machine, as Emcloz 0.25 Tablet can make you drowsy.
Is it safe?
Emcloz 0.25 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Emcloz 0.25 Tablet has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Emcloz 0.25 Tablet
Emcloz 0.25 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Emcloz 0.25 Tablet
Consuming Emcloz 0.25 Tablet with alcohol can have many serious effects on your body.
No, Emcloz does not cause weight gain. However, if you gain weight after taking Emcloz, discuss it with your doctor.
Yes, it can lower the heart rate but this occurs rarely. The exact cause behind this is unknown. If you are experiencing low heart rate after taking this drug, consult your doctor immediately without any further delay.
Emcloz comes in form of a tablet and it should be taken by mouth once daily or as advised by your doctor. Precautions must be taken in patients with chronic pulmonary insufficiency, personality disorders, muscle weakness, impaired liver or kidney function. Do not drive any vehicle or operate machinery after taking this medicine as it can cause drowsiness or sedation.
No, Emcloz does not cause low blood pressure at regular doses. However, it may cause low blood pressure if it is taken in higher doses. If you are experiencing low blood pressure after taking this drug, then please consult your doctor immediately without any further delay.
Yes, Emcloz is safe to use, if taken in prescribed amount for a specified time as advised by the doctor. However, some side effects are observed at regular doses these are drowsiness, dizziness, problems with coordination, and difficulty thinking. Do not hesitate to inform your doctor if you are facing any of the above.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Klonopin (clonazepam)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 418
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 330-332
